ALEXANDRIA, Va., July 16 -- United States Patent no. 12,359,259, issued on July 15, was assigned to ACADEMIA SINICA (Taipei, Taiwan).
"Biomarkers for predicting prostate cancer progression" was invented by Pei-Wen Hsiao (Taipei, Taiwan), Chin-Hsien Tsai (Taipei, Taiwan), Sheue-Fen Tzeng (Taipei, Taiwan), Shih-Chuan Hsieh (Jiaoxi Township, Taiwan) and Ming-Shyue Lee (New Taipei, Taiwan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to biomarkers, methods and assay kits for predicting prognosis and/or monitoring progression of prostate cancer. The biomarkers include a glycosyltransferases [core 1 beta-3-galactosyltransferase (C1GALT1) and/or ST3 beta-galactoside alpha-2,3-sialyltr...